Cargando…
Rapid modification of the bone microenvironment following short-term treatment with Cabozantinib in vivo
INTRODUCTION: Bone metastasis remains incurable with treatment restricted to palliative care. Cabozantinib (CBZ) is targeted against multiple receptor tyrosine kinases involved in tumour pathobiology, including hepatocyte growth factor receptor (MET) and vascular endothelial growth factor receptor 2...
Autores principales: | Haider, Marie-Therese, Hunter, Keith D., Robinson, Simon P., Graham, Timothy J., Corey, Eva, Dear, T. Neil, Hughes, Russell, Brown, Nicola J., Holen, Ingunn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768060/ https://www.ncbi.nlm.nih.gov/pubmed/26279137 http://dx.doi.org/10.1016/j.bone.2015.08.003 |
Ejemplares similares
-
Modifying the osteoblastic niche with zoledronic acid in vivo—Potential implications for breast cancer bone metastasis
por: Haider, Marie-Therese, et al.
Publicado: (2014) -
Modulation of cabozantinib efficacy by the prostate tumor microenvironment
por: Tripathi, Manisha, et al.
Publicado: (2017) -
Age-related type I collagen modifications reveal tissue-defining differences between ligament and tendon
por: Hudson, David M., et al.
Publicado: (2021) -
The bone microenvironment - Multiple players involved in cancer progression
por: Holen, Ingunn
Publicado: (2016) -
A pilot study of a clinician-guided internet-delivered cognitive behavioural therapy for anxiety and depression among Arabs in Australia, presented in both English and Arabic languages
por: Kayrouz, Rony, et al.
Publicado: (2016)